human central nervous system stem cells
Cell therapyexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01005004)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- human central nervous system stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02467634 | Phase 2 | Jun 1, 2015 | StemCells, Inc. |
| NCT02163876 | Phase 2 | Oct 1, 2014 | StemCells, Inc. |
| NCT01632527 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2012 | StemCells, Inc. |
| NCT01321333 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2011 | StemCells, Inc. |
| NCT01238315 | Phase 1 | Nov 1, 2010 | Oregon Health and Science University, StemCells, Inc. |
| NCT01005004 | Phase 1 | Nov 1, 2009 | StemCells, Inc. |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| StemCells, Inc. | For profit | 6 | 6 | 2 | 2009 |
| Oregon Health and Science University | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1